CME Group Inc.
CME
$265.56
$5.232.01%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.60% | 17.73% | 11.20% | 1.34% | 19.13% |
| Total Other Revenue | 27.85% | 29.68% | 37.70% | 38.39% | 20.20% |
| Total Revenue | 5.98% | 18.47% | 12.69% | 3.22% | 19.20% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 5.98% | 18.47% | 12.69% | 3.22% | 19.20% |
| SG&A Expenses | 3.89% | 10.37% | 3.52% | 1.68% | 9.14% |
| Depreciation & Amortization | -3.36% | -4.98% | -5.71% | -3.83% | -4.75% |
| Other Operating Expenses | 10.58% | 17.21% | 4.16% | -6.15% | -31.12% |
| Total Operating Expenses | 3.52% | 8.27% | 1.98% | 0.10% | 0.13% |
| Operating Income | 7.51% | 24.87% | 19.32% | 5.02% | 35.22% |
| Income Before Tax | 9.01% | 20.79% | 13.59% | -3.76% | 21.60% |
| Income Tax Expenses | 15.99% | 17.85% | 13.61% | -5.46% | 1.06% |
| Earnings from Continuing Operations | 7.37% | 21.67% | 13.58% | -3.24% | 27.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.37% | 21.67% | 13.58% | -3.24% | 27.70% |
| EBIT | 7.51% | 24.87% | 19.32% | 5.02% | 35.22% |
| EBITDA | 6.54% | 21.97% | 16.91% | 4.24% | 30.36% |
| EPS Basic | 7.27% | 21.54% | 13.46% | -3.33% | 27.56% |
| Normalized Basic EPS | 7.98% | 20.67% | 13.46% | -3.85% | 21.50% |
| EPS Diluted | 7.19% | 21.36% | 13.13% | -3.29% | 27.56% |
| Normalized Diluted EPS | 7.99% | 20.67% | 13.45% | -3.90% | 21.43% |
| Average Basic Shares Outstanding | 0.10% | 0.11% | 0.11% | 0.09% | 0.09% |
| Average Diluted Shares Outstanding | 0.10% | 0.10% | 0.12% | 0.14% | 0.14% |
| Dividend Per Share | 4.55% | 4.55% | 4.55% | 4.55% | 10.00% |
| Payout Ratio | -0.03% | -0.14% | -0.08% | 0.18% | -0.14% |